NCT02197442View on ClinicalTrials.gov

Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy
Interventions
DRUG

Valsartan

Trial Locations (1)

380 061

Lambda Therapeutic Research Ltd.,, Ahmedabad

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT02197442 - Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter